Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.77298200 |
2 | phospholipid homeostasis (GO:0055091) | 4.60984484 |
3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.21481270 |
4 | macroautophagy (GO:0016236) | 4.11675218 |
5 | B cell receptor signaling pathway (GO:0050853) | 4.09008865 |
6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.08592175 |
7 | positive regulation of granulocyte differentiation (GO:0030854) | 3.80968078 |
8 | negative T cell selection (GO:0043383) | 3.72744785 |
9 | negative thymic T cell selection (GO:0045060) | 3.67117987 |
10 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.64663374 |
11 | interkinetic nuclear migration (GO:0022027) | 3.63920385 |
12 | positive T cell selection (GO:0043368) | 3.57371916 |
13 | lipoprotein transport (GO:0042953) | 3.37910319 |
14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.35470785 |
15 | negative regulation of cell killing (GO:0031342) | 3.35470785 |
16 | regulation of sequestering of triglyceride (GO:0010889) | 3.34051633 |
17 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.28138431 |
18 | microglial cell activation (GO:0001774) | 3.28135449 |
19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.23989444 |
20 | low-density lipoprotein particle clearance (GO:0034383) | 3.21990634 |
21 | cellular extravasation (GO:0045123) | 3.21876273 |
22 | histone H3-K4 trimethylation (GO:0080182) | 3.19393998 |
23 | apoptotic cell clearance (GO:0043277) | 3.19318982 |
24 | detection of molecule of bacterial origin (GO:0032490) | 3.16514986 |
25 | regulation of cholesterol storage (GO:0010885) | 3.16301320 |
26 | regulation of ARF protein signal transduction (GO:0032012) | 3.15804255 |
27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14996059 |
28 | positive thymic T cell selection (GO:0045059) | 3.10874657 |
29 | activated T cell proliferation (GO:0050798) | 3.04550789 |
30 | mannose metabolic process (GO:0006013) | 3.02860456 |
31 | hepatocyte apoptotic process (GO:0097284) | 3.02112411 |
32 | establishment of protein localization to Golgi (GO:0072600) | 3.01639351 |
33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01248564 |
34 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.99978285 |
35 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.97227534 |
36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96645020 |
37 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94488023 |
38 | definitive hemopoiesis (GO:0060216) | 2.91421011 |
39 | urea cycle (GO:0000050) | 2.89969385 |
40 | urea metabolic process (GO:0019627) | 2.89969385 |
41 | T cell selection (GO:0045058) | 2.87985468 |
42 | positive regulation of B cell differentiation (GO:0045579) | 2.87355209 |
43 | nucleus localization (GO:0051647) | 2.86413635 |
44 | fatty acid transmembrane transport (GO:1902001) | 2.85168561 |
45 | positive regulation of p38MAPK cascade (GO:1900745) | 2.84396582 |
46 | regulation of beta-amyloid formation (GO:1902003) | 2.83698530 |
47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82337918 |
48 | positive regulation of cholesterol efflux (GO:0010875) | 2.82309538 |
49 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.81466693 |
50 | response to interleukin-15 (GO:0070672) | 2.80739725 |
51 | protein targeting to Golgi (GO:0000042) | 2.80531298 |
52 | regulation of B cell differentiation (GO:0045577) | 2.80214512 |
53 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.79020245 |
54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78704082 |
55 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.76596038 |
56 | positive regulation of histone deacetylation (GO:0031065) | 2.76392955 |
57 | carnitine shuttle (GO:0006853) | 2.74455018 |
58 | macrophage activation (GO:0042116) | 2.74133943 |
59 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73696701 |
60 | regulation of pigment cell differentiation (GO:0050932) | 2.73255893 |
61 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.73189908 |
62 | neutrophil mediated immunity (GO:0002446) | 2.72549027 |
63 | T cell migration (GO:0072678) | 2.72364916 |
64 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71591182 |
65 | modulation by symbiont of host defense response (GO:0052031) | 2.71591182 |
66 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71591182 |
67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71591182 |
68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71591182 |
69 | modulation by symbiont of host immune response (GO:0052553) | 2.71591182 |
70 | negative regulation of B cell proliferation (GO:0030889) | 2.70962074 |
71 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.70417291 |
72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69675334 |
73 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.68491503 |
74 | positive regulation of Rap GTPase activity (GO:0032854) | 2.68167485 |
75 | complement activation, alternative pathway (GO:0006957) | 2.68057090 |
76 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.67584737 |
77 | alpha-linolenic acid metabolic process (GO:0036109) | 2.67117990 |
78 | interferon-gamma production (GO:0032609) | 2.67075157 |
79 | positive regulation of cholesterol transport (GO:0032376) | 2.66440488 |
80 | positive regulation of sterol transport (GO:0032373) | 2.66440488 |
81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.65655005 |
82 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.64255029 |
83 | regulation of protein polyubiquitination (GO:1902914) | 2.63812973 |
84 | alanine transport (GO:0032328) | 2.61004123 |
85 | protein targeting to lysosome (GO:0006622) | 2.60147267 |
86 | establishment of protein localization to vacuole (GO:0072666) | 2.60147267 |
87 | protein targeting to vacuole (GO:0006623) | 2.60147267 |
88 | negative regulation of granulocyte differentiation (GO:0030853) | 2.60022344 |
89 | negative regulation of neurotransmitter transport (GO:0051589) | 2.59596912 |
90 | negative regulation of lipid storage (GO:0010888) | 2.58935814 |
91 | cellular response to interleukin-15 (GO:0071350) | 2.57441153 |
92 | protein K48-linked deubiquitination (GO:0071108) | 2.57351249 |
93 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.56509970 |
94 | plasma lipoprotein particle clearance (GO:0034381) | 2.55863043 |
95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.55836339 |
96 | establishment of nucleus localization (GO:0040023) | 2.55385524 |
97 | early endosome to late endosome transport (GO:0045022) | 2.55285626 |
98 | protein K11-linked deubiquitination (GO:0035871) | 2.54879902 |
99 | negative regulation of adaptive immune response (GO:0002820) | 2.54695979 |
100 | I-kappaB phosphorylation (GO:0007252) | 2.53698498 |
101 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.52477571 |
102 | regulation of granulocyte differentiation (GO:0030852) | 2.51479734 |
103 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.51104553 |
104 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.51104553 |
105 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.51104553 |
106 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.49815788 |
107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.49631923 |
108 | mature B cell differentiation (GO:0002335) | 2.49068228 |
109 | histone mRNA catabolic process (GO:0071044) | 2.48851980 |
110 | cellular response to ethanol (GO:0071361) | 2.48035758 |
111 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.47879771 |
112 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47663263 |
113 | positive regulation of developmental pigmentation (GO:0048087) | 2.47630968 |
114 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.47427690 |
115 | histone H3-K9 demethylation (GO:0033169) | 2.46227618 |
116 | growth hormone receptor signaling pathway (GO:0060396) | 2.43881900 |
117 | Golgi to endosome transport (GO:0006895) | 2.43787689 |
118 | phospholipid dephosphorylation (GO:0046839) | 2.43714610 |
119 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.43622372 |
120 | regulation of tolerance induction (GO:0002643) | 2.43480995 |
121 | detection of external biotic stimulus (GO:0098581) | 2.43386003 |
122 | nitrogen cycle metabolic process (GO:0071941) | 2.43287058 |
123 | regulation of Rap GTPase activity (GO:0032317) | 2.42066436 |
124 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.41168829 |
125 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.41168829 |
126 | positive regulation of fatty acid oxidation (GO:0046321) | 2.40419212 |
127 | B cell proliferation (GO:0042100) | 2.39865729 |
128 | positive regulation of lipid catabolic process (GO:0050996) | 2.37973115 |
129 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.37568262 |
130 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.37229799 |
131 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.37138177 |
132 | histone H3-K4 methylation (GO:0051568) | 2.35859114 |
133 | NLS-bearing protein import into nucleus (GO:0006607) | 2.35794260 |
134 | thymic T cell selection (GO:0045061) | 2.35252009 |
135 | positive regulation of glycolytic process (GO:0045821) | 2.35065036 |
136 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.34177963 |
137 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.34167616 |
138 | glycogen catabolic process (GO:0005980) | 2.34080516 |
139 | positive regulation of tolerance induction (GO:0002645) | 2.33777653 |
140 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.33287921 |
141 | detection of other organism (GO:0098543) | 2.32911102 |
142 | intracellular lipid transport (GO:0032365) | 2.30250008 |
143 | neural tube formation (GO:0001841) | 2.30148149 |
144 | T-helper cell differentiation (GO:0042093) | 2.29974742 |
145 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.29974742 |
146 | fatty acid homeostasis (GO:0055089) | 2.29395632 |
147 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.27225576 |
148 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.25429583 |
149 | plasma lipoprotein particle assembly (GO:0034377) | 2.25116438 |
150 | protein-lipid complex assembly (GO:0065005) | 2.24594416 |
151 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.23295180 |
152 | positive regulation of phagocytosis (GO:0050766) | 2.22746898 |
153 | macrophage activation involved in immune response (GO:0002281) | 2.20893514 |
154 | regulation of apoptotic cell clearance (GO:2000425) | 2.20749781 |
155 | glucan catabolic process (GO:0009251) | 2.20593853 |
156 | regulation of integrin activation (GO:0033623) | 2.20241457 |
157 | phospholipid efflux (GO:0033700) | 2.19754081 |
158 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.19275535 |
159 | cholesterol efflux (GO:0033344) | 2.19193956 |
160 | protein carboxylation (GO:0018214) | 2.18455442 |
161 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.18455442 |
162 | cellular polysaccharide catabolic process (GO:0044247) | 2.18304307 |
163 | histone H3-K36 demethylation (GO:0070544) | 2.17660516 |
164 | sodium ion export (GO:0071436) | 2.16282296 |
165 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.15638810 |
166 | peptidyl-lysine trimethylation (GO:0018023) | 2.13590997 |
167 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.13262273 |
168 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.13095068 |
169 | phospholipid translocation (GO:0045332) | 2.12178738 |
170 | lipid translocation (GO:0034204) | 2.12178738 |
171 | vesicle transport along microtubule (GO:0047496) | 2.11898158 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GATA1_22025678_ChIP-Seq_K562_Human | 2.69719363 |
2 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.68697125 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.59488433 |
4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58920569 |
5 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.42997258 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42912612 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42047293 |
8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.27731011 |
9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17816411 |
10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.16356055 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14841357 |
12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14014501 |
13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.99800745 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94073584 |
15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.85704445 |
16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.82919711 |
17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.81523019 |
18 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77945372 |
19 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75130470 |
20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69284800 |
21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68746591 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68463654 |
23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65915432 |
24 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65453890 |
25 | TP53_16413492_ChIP-PET_HCT116_Human | 1.64816282 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62504743 |
27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60057368 |
28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59385497 |
29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57217731 |
30 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.55526399 |
31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54912660 |
32 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.54545584 |
33 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.47719058 |
34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47194950 |
35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46677800 |
36 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43848533 |
37 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41882246 |
38 | MYB_26560356_Chip-Seq_TH2_Human | 1.41833354 |
39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39046693 |
40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.38290444 |
41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37792194 |
42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37009567 |
43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36822932 |
44 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36079928 |
45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35749893 |
46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34607716 |
47 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34086021 |
48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33719024 |
49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.32865471 |
50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32711319 |
51 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32466553 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32303969 |
53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30364310 |
54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29321283 |
55 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29270155 |
56 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.29130803 |
57 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28963823 |
58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28556540 |
59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28244845 |
60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27801461 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27542633 |
62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.27311496 |
63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27247065 |
64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27007635 |
65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26390089 |
66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26156515 |
67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26033900 |
68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25914264 |
69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23845331 |
70 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23712162 |
71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23147474 |
72 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23083227 |
73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22315796 |
74 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21836713 |
75 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20661519 |
76 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18883945 |
77 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17437842 |
78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.17368328 |
79 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17164037 |
80 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16636756 |
81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16389901 |
82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16229607 |
83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15230708 |
84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14937674 |
85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.14073273 |
86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13893611 |
87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13715736 |
88 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13355559 |
89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12865497 |
90 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12476579 |
91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12444801 |
92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12125147 |
93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11584687 |
94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11539948 |
95 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11252763 |
96 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11193197 |
97 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10941420 |
98 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10772006 |
99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10561883 |
100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10548343 |
101 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10326458 |
102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10237745 |
103 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09665413 |
104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08782801 |
105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08709166 |
106 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08451189 |
107 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08252171 |
108 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08246712 |
109 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07442617 |
110 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07406669 |
111 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06903395 |
112 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06759500 |
113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06054070 |
114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05708925 |
115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05553628 |
116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05193614 |
117 | AR_19668381_ChIP-Seq_PC3_Human | 1.04483716 |
118 | MYB_26560356_Chip-Seq_TH1_Human | 1.04202445 |
119 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03599879 |
120 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03429661 |
121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02818725 |
122 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02607899 |
123 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01245659 |
124 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01245659 |
125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01166146 |
126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00612599 |
127 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00537639 |
128 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00534919 |
129 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.00478394 |
130 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99818493 |
131 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99375926 |
132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98130383 |
133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98130383 |
134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97064655 |
135 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96505628 |
136 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96314179 |
137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95895517 |
138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95577140 |
139 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.95542835 |
140 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.95489893 |
141 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95325283 |
142 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94827111 |
143 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93994432 |
144 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92915461 |
145 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.92758155 |
146 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92270064 |
147 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91744907 |
148 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91692335 |
149 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90424052 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 8.75569937 |
2 | MP0008057_abnormal_DNA_replication | 3.73825024 |
3 | MP0003172_abnormal_lysosome_physiology | 3.56094655 |
4 | MP0002009_preneoplasia | 3.38419144 |
5 | MP0003763_abnormal_thymus_physiology | 3.02421480 |
6 | MP0005670_abnormal_white_adipose | 2.89089131 |
7 | MP0005058_abnormal_lysosome_morphology | 2.78421514 |
8 | MP0005365_abnormal_bile_salt | 2.71142286 |
9 | MP0003724_increased_susceptibility_to | 2.63796722 |
10 | MP0004130_abnormal_muscle_cell | 2.54924974 |
11 | MP0003300_gastrointestinal_ulcer | 2.52975925 |
12 | MP0002139_abnormal_hepatobiliary_system | 2.46930994 |
13 | MP0005360_urolithiasis | 2.41925846 |
14 | MP0001800_abnormal_humoral_immune | 2.32674048 |
15 | MP0005174_abnormal_tail_pigmentation | 2.27997196 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.19722603 |
17 | MP0003252_abnormal_bile_duct | 2.19040010 |
18 | MP0003183_abnormal_peptide_metabolism | 2.15344373 |
19 | MP0003045_fibrosis | 2.13346665 |
20 | MP0010329_abnormal_lipoprotein_level | 2.12336534 |
21 | MP0002166_altered_tumor_susceptibility | 2.02375890 |
22 | MP0004859_abnormal_synaptic_plasticity | 1.99893015 |
23 | MP0000685_abnormal_immune_system | 1.96613795 |
24 | MP0005310_abnormal_salivary_gland | 1.95049852 |
25 | MP0000015_abnormal_ear_pigmentation | 1.93815545 |
26 | MP0005671_abnormal_response_to | 1.91365701 |
27 | MP0000371_diluted_coat_color | 1.91097455 |
28 | MP0001790_abnormal_immune_system | 1.88442428 |
29 | MP0005387_immune_system_phenotype | 1.88442428 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.84437461 |
31 | MP0009780_abnormal_chondrocyte_physiolo | 1.79000861 |
32 | MP0005085_abnormal_gallbladder_physiolo | 1.71118653 |
33 | MP0004510_myositis | 1.70212638 |
34 | MP0002723_abnormal_immune_serum | 1.69894312 |
35 | MP0002452_abnormal_antigen_presenting | 1.68775840 |
36 | MP0005666_abnormal_adipose_tissue | 1.68364217 |
37 | MP0005000_abnormal_immune_tolerance | 1.63989810 |
38 | MP0002420_abnormal_adaptive_immunity | 1.63756823 |
39 | MP0003690_abnormal_glial_cell | 1.63258048 |
40 | MP0004883_abnormal_blood_vessel | 1.62395767 |
41 | MP0010307_abnormal_tumor_latency | 1.60096430 |
42 | MP0001819_abnormal_immune_cell | 1.60010715 |
43 | MP0005076_abnormal_cell_differentiation | 1.54387890 |
44 | MP0003866_abnormal_defecation | 1.54125696 |
45 | MP0008961_abnormal_basal_metabolism | 1.52183747 |
46 | MP0004808_abnormal_hematopoietic_stem | 1.50622999 |
47 | MP0000604_amyloidosis | 1.49728883 |
48 | MP0002405_respiratory_system_inflammati | 1.49551399 |
49 | MP0006054_spinal_hemorrhage | 1.47206203 |
50 | MP0000465_gastrointestinal_hemorrhage | 1.47108479 |
51 | MP0003828_pulmonary_edema | 1.46202972 |
52 | MP0003303_peritoneal_inflammation | 1.45776899 |
53 | MP0009840_abnormal_foam_cell | 1.43364558 |
54 | MP0005025_abnormal_response_to | 1.42295319 |
55 | MP0003566_abnormal_cell_adhesion | 1.42198689 |
56 | MP0004185_abnormal_adipocyte_glucose | 1.41958994 |
57 | MP0002398_abnormal_bone_marrow | 1.40796013 |
58 | MP0004381_abnormal_hair_follicle | 1.40705022 |
59 | MP0005083_abnormal_biliary_tract | 1.39199597 |
60 | MP0004484_altered_response_of | 1.35219917 |
61 | MP0000609_abnormal_liver_physiology | 1.34056243 |
62 | MP0002118_abnormal_lipid_homeostasis | 1.33699540 |
63 | MP0008438_abnormal_cutaneous_collagen | 1.32538715 |
64 | MP0002006_tumorigenesis | 1.32103965 |
65 | MP0000716_abnormal_immune_system | 1.31490192 |
66 | MP0005075_abnormal_melanosome_morpholog | 1.30421392 |
67 | MP0005464_abnormal_platelet_physiology | 1.29794501 |
68 | MP0006082_CNS_inflammation | 1.29614958 |
69 | MP0000689_abnormal_spleen_morphology | 1.28028694 |
70 | MP0005375_adipose_tissue_phenotype | 1.25880074 |
71 | MP0000703_abnormal_thymus_morphology | 1.23200222 |
72 | MP0009785_altered_susceptibility_to | 1.22010439 |
73 | MP0009278_abnormal_bone_marrow | 1.21932411 |
74 | MP0002971_abnormal_brown_adipose | 1.19930743 |
75 | MP0002928_abnormal_bile_duct | 1.17617865 |
76 | MP0002837_dystrophic_cardiac_calcinosis | 1.15621362 |
77 | MP0003868_abnormal_feces_composition | 1.15134839 |
78 | MP0001851_eye_inflammation | 1.15041578 |
79 | MP0010155_abnormal_intestine_physiology | 1.14961060 |
80 | MP0010678_abnormal_skin_adnexa | 1.14706034 |
81 | MP0003787_abnormal_imprinting | 1.11836238 |
82 | MP0002722_abnormal_immune_system | 1.11644366 |
83 | MP0005334_abnormal_fat_pad | 1.09601421 |
84 | MP0000383_abnormal_hair_follicle | 1.08707538 |
85 | MP0000003_abnormal_adipose_tissue | 1.04999498 |
86 | MP0001661_extended_life_span | 1.04340146 |
87 | MP0003091_abnormal_cell_migration | 1.04144580 |
88 | MP0001845_abnormal_inflammatory_respons | 1.03884356 |
89 | MP0005164_abnormal_response_to | 1.03876679 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 1.03090600 |
91 | MP0002078_abnormal_glucose_homeostasis | 1.01598719 |
92 | MP0004134_abnormal_chest_morphology | 1.01003807 |
93 | MP0008260_abnormal_autophagy | 0.99353484 |
94 | MP0002254_reproductive_system_inflammat | 0.99122721 |
95 | MP0002909_abnormal_adrenal_gland | 0.99013651 |
96 | MP0002419_abnormal_innate_immunity | 0.98352879 |
97 | MP0002168_other_aberrant_phenotype | 0.96698837 |
98 | MP0008877_abnormal_DNA_methylation | 0.95360787 |
99 | MP0003075_altered_response_to | 0.93901108 |
100 | MP0005409_darkened_coat_color | 0.91545338 |
101 | MP0009115_abnormal_fat_cell | 0.91507085 |
102 | MP0004947_skin_inflammation | 0.91026390 |
103 | MP0003633_abnormal_nervous_system | 0.90968147 |
104 | MP0002429_abnormal_blood_cell | 0.89078315 |
105 | MP0000013_abnormal_adipose_tissue | 0.85828242 |
106 | MP0010630_abnormal_cardiac_muscle | 0.84496010 |
107 | MP0000751_myopathy | 0.83332769 |
108 | MP0005448_abnormal_energy_balance | 0.81934170 |
109 | MP0002332_abnormal_exercise_endurance | 0.81531983 |
110 | MP0009763_increased_sensitivity_to | 0.79295732 |
111 | MP0003436_decreased_susceptibility_to | 0.78570271 |
112 | MP0009046_muscle_twitch | 0.78392034 |
113 | MP0003195_calcinosis | 0.78243663 |
114 | MP0001666_abnormal_nutrient_absorption | 0.78121977 |
115 | MP0002933_joint_inflammation | 0.78094729 |
116 | MP0000249_abnormal_blood_vessel | 0.77577231 |
117 | MP0005379_endocrine/exocrine_gland_phen | 0.76605452 |
118 | MP0002269_muscular_atrophy | 0.76406925 |
119 | MP0004087_abnormal_muscle_fiber | 0.76265347 |
120 | MP0002693_abnormal_pancreas_physiology | 0.76048522 |
121 | MP0005535_abnormal_body_temperature | 0.75823206 |
122 | MP0001873_stomach_inflammation | 0.75764565 |
123 | MP0002075_abnormal_coat/hair_pigmentati | 0.75137414 |
124 | MP0005167_abnormal_blood-brain_barrier | 0.75136282 |
125 | MP0010386_abnormal_urinary_bladder | 0.74837470 |
126 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73087121 |
127 | MP0002877_abnormal_melanocyte_morpholog | 0.71667712 |
128 | MP0002148_abnormal_hypersensitivity_rea | 0.71182026 |
129 | MP0001958_emphysema | 0.71090413 |
130 | MP0004036_abnormal_muscle_relaxation | 0.69196055 |
131 | MP0002970_abnormal_white_adipose | 0.68101562 |
132 | MP0009672_abnormal_birth_weight | 0.67639103 |
133 | MP0005319_abnormal_enzyme/_coenzyme | 0.66850188 |
134 | MP0005220_abnormal_exocrine_pancreas | 0.66131537 |
135 | MP0002090_abnormal_vision | 0.66075944 |
136 | MP0008004_abnormal_stomach_pH | 0.65898331 |
137 | MP0000920_abnormal_myelination | 0.65583217 |
138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65304448 |
139 | MP0000598_abnormal_liver_morphology | 0.65301433 |
140 | MP0010352_gastrointestinal_tract_polyps | 0.65281454 |
141 | MP0004084_abnormal_cardiac_muscle | 0.64845482 |
142 | MP0003631_nervous_system_phenotype | 0.63809318 |
143 | MP0000427_abnormal_hair_cycle | 0.62746158 |
144 | MP0001324_abnormal_eye_pigmentation | 0.62190649 |
145 | MP0001545_abnormal_hematopoietic_system | 0.61789688 |
146 | MP0005397_hematopoietic_system_phenotyp | 0.61789688 |
147 | MP0010234_abnormal_vibrissa_follicle | 0.61255807 |
148 | MP0009703_decreased_birth_body | 0.60997490 |
149 | MP0003632_abnormal_nervous_system | 0.60578325 |
150 | MP0004215_abnormal_myocardial_fiber | 0.58935516 |
151 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57614274 |
152 | MP0001835_abnormal_antigen_presentation | 0.56055030 |
153 | MP0002998_abnormal_bone_remodeling | 0.55103134 |
154 | MP0000747_muscle_weakness | 0.53859251 |
155 | MP0001915_intracranial_hemorrhage | 0.52910107 |
156 | MP0005621_abnormal_cell_physiology | 0.52394525 |
157 | MP0005257_abnormal_intraocular_pressure | 0.49944398 |
158 | MP0002396_abnormal_hematopoietic_system | 0.49706609 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 4.57743572 |
2 | Abnormality of T cell number (HP:0011839) | 4.19823464 |
3 | Papillary thyroid carcinoma (HP:0002895) | 3.58712141 |
4 | Thyroiditis (HP:0100646) | 3.44689307 |
5 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.27660572 |
6 | Recurrent cutaneous fungal infections (HP:0011370) | 3.27660572 |
7 | Recurrent fungal infections (HP:0002841) | 3.15757777 |
8 | Abnormality of the fingertips (HP:0001211) | 3.13398247 |
9 | Recurrent bronchitis (HP:0002837) | 3.04059616 |
10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04043101 |
11 | Spontaneous hematomas (HP:0007420) | 2.99200335 |
12 | Cerebral aneurysm (HP:0004944) | 2.96673787 |
13 | Recurrent skin infections (HP:0001581) | 2.91915485 |
14 | Macroorchidism (HP:0000053) | 2.90673164 |
15 | Global brain atrophy (HP:0002283) | 2.87404109 |
16 | Narrow palate (HP:0000189) | 2.70991463 |
17 | Recurrent viral infections (HP:0004429) | 2.69659519 |
18 | Chronic diarrhea (HP:0002028) | 2.69408972 |
19 | Periodontitis (HP:0000704) | 2.69007563 |
20 | Myocardial infarction (HP:0001658) | 2.64777535 |
21 | Abnormality of T cells (HP:0002843) | 2.61048770 |
22 | Complement deficiency (HP:0004431) | 2.56811934 |
23 | Subacute progressive viral hepatitis (HP:0006572) | 2.54225124 |
24 | Hypoalphalipoproteinemia (HP:0003233) | 2.51576323 |
25 | Inflammation of the large intestine (HP:0002037) | 2.50562483 |
26 | Acute myeloid leukemia (HP:0004808) | 2.50165985 |
27 | Recurrent bacterial skin infections (HP:0005406) | 2.49782309 |
28 | Gastrointestinal infarctions (HP:0005244) | 2.49710915 |
29 | Urethral obstruction (HP:0000796) | 2.47489337 |
30 | Absent frontal sinuses (HP:0002688) | 2.47443778 |
31 | Viral hepatitis (HP:0006562) | 2.44003895 |
32 | Gaze-evoked nystagmus (HP:0000640) | 2.40793026 |
33 | Skin nodule (HP:0200036) | 2.39974206 |
34 | Deep venous thrombosis (HP:0002625) | 2.39066556 |
35 | Autoimmune hemolytic anemia (HP:0001890) | 2.38977024 |
36 | Thyroid carcinoma (HP:0002890) | 2.38895574 |
37 | Conjunctival telangiectasia (HP:0000524) | 2.36635982 |
38 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.36074975 |
39 | Heterotopia (HP:0002282) | 2.35411467 |
40 | Long toe (HP:0010511) | 2.34542421 |
41 | Joint hemorrhage (HP:0005261) | 2.34272075 |
42 | Widely spaced teeth (HP:0000687) | 2.33920964 |
43 | Stomatitis (HP:0010280) | 2.33254049 |
44 | Retrobulbar optic neuritis (HP:0100654) | 2.33064339 |
45 | Optic neuritis (HP:0100653) | 2.33064339 |
46 | Dysmetric saccades (HP:0000641) | 2.31939693 |
47 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30894164 |
48 | Gingivitis (HP:0000230) | 2.30290258 |
49 | Glucose intolerance (HP:0000833) | 2.29794046 |
50 | Autoimmune thrombocytopenia (HP:0001973) | 2.28133271 |
51 | Turricephaly (HP:0000262) | 2.25485374 |
52 | Papilledema (HP:0001085) | 2.25373236 |
53 | Epidermoid cyst (HP:0200040) | 2.24703473 |
54 | Panhypogammaglobulinemia (HP:0003139) | 2.24180035 |
55 | Increased cerebral lipofuscin (HP:0011813) | 2.21645305 |
56 | Hyperventilation (HP:0002883) | 2.21377938 |
57 | Fair hair (HP:0002286) | 2.20403836 |
58 | Xanthomatosis (HP:0000991) | 2.20088321 |
59 | Hypercholesterolemia (HP:0003124) | 2.20070983 |
60 | Aneurysm (HP:0002617) | 2.19518759 |
61 | Agammaglobulinemia (HP:0004432) | 2.16965012 |
62 | Recurrent abscess formation (HP:0002722) | 2.16954426 |
63 | Gastrointestinal inflammation (HP:0004386) | 2.16188398 |
64 | Abnormal glucose tolerance (HP:0001952) | 2.14874841 |
65 | Frequent falls (HP:0002359) | 2.14407301 |
66 | Distal lower limb amyotrophy (HP:0008944) | 2.14316247 |
67 | Myositis (HP:0100614) | 2.13081564 |
68 | Meningitis (HP:0001287) | 2.13034657 |
69 | Hemiplegia (HP:0002301) | 2.12872982 |
70 | Leukocytosis (HP:0001974) | 2.12497384 |
71 | Vasculitis (HP:0002633) | 2.11045747 |
72 | Gingival bleeding (HP:0000225) | 2.10893419 |
73 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10233660 |
74 | Generalized hypopigmentation of hair (HP:0011358) | 2.08893567 |
75 | Upper motor neuron abnormality (HP:0002127) | 2.07902436 |
76 | Menstrual irregularities (HP:0000858) | 2.07146547 |
77 | Chest pain (HP:0100749) | 2.06265240 |
78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05980693 |
79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05980693 |
80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05980693 |
81 | Hypoglycemic seizures (HP:0002173) | 2.05761920 |
82 | Hematochezia (HP:0002573) | 2.05652867 |
83 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05510129 |
84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05510129 |
85 | Increased CSF protein (HP:0002922) | 2.05224316 |
86 | Hypoglycemic coma (HP:0001325) | 2.04302761 |
87 | Hand muscle atrophy (HP:0009130) | 2.04118381 |
88 | Mediastinal lymphadenopathy (HP:0100721) | 2.02224312 |
89 | IgA deficiency (HP:0002720) | 2.02147569 |
90 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01031137 |
91 | Neurodegeneration (HP:0002180) | 2.00795989 |
92 | Abnormality of eosinophils (HP:0001879) | 2.00624668 |
93 | Distal upper limb amyotrophy (HP:0007149) | 2.00520581 |
94 | Upper limb amyotrophy (HP:0009129) | 2.00520581 |
95 | Lower limb amyotrophy (HP:0007210) | 1.99998717 |
96 | Orchitis (HP:0100796) | 1.99564701 |
97 | Scanning speech (HP:0002168) | 1.99437877 |
98 | Abnormality of the thoracic spine (HP:0100711) | 1.98932425 |
99 | Overgrowth (HP:0001548) | 1.98880598 |
100 | Hemoptysis (HP:0002105) | 1.98606236 |
101 | Arterial thrombosis (HP:0004420) | 1.98279227 |
102 | Mitral stenosis (HP:0001718) | 1.97905722 |
103 | Hyperlipoproteinemia (HP:0010980) | 1.97875215 |
104 | Intrahepatic cholestasis (HP:0001406) | 1.94747577 |
105 | IgM deficiency (HP:0002850) | 1.94723122 |
106 | Excessive salivation (HP:0003781) | 1.94196354 |
107 | Drooling (HP:0002307) | 1.94196354 |
108 | Abnormality of the common coagulation pathway (HP:0010990) | 1.93310739 |
109 | Coarse hair (HP:0002208) | 1.92598320 |
110 | Hyperkalemia (HP:0002153) | 1.90796860 |
111 | Neonatal hypoglycemia (HP:0001998) | 1.89081005 |
112 | Stomach cancer (HP:0012126) | 1.88890935 |
113 | Blue irides (HP:0000635) | 1.88048313 |
114 | Genetic anticipation (HP:0003743) | 1.87845461 |
115 | Abnormality of vision evoked potentials (HP:0000649) | 1.87411685 |
116 | Truncal obesity (HP:0001956) | 1.86802637 |
117 | Eosinophilia (HP:0001880) | 1.85509819 |
118 | Osteomyelitis (HP:0002754) | 1.85298464 |
119 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.85160179 |
120 | Prolonged bleeding time (HP:0003010) | 1.84883795 |
121 | Generalized hypopigmentation (HP:0007513) | 1.84020292 |
122 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.83690547 |
123 | Severe combined immunodeficiency (HP:0004430) | 1.83263787 |
124 | Ketosis (HP:0001946) | 1.83113641 |
125 | Pulmonary infiltrates (HP:0002113) | 1.82001515 |
126 | Abnormality of macrophages (HP:0004311) | 1.81837355 |
127 | Bronchitis (HP:0012387) | 1.81525079 |
128 | Postural instability (HP:0002172) | 1.81296546 |
129 | Mucopolysacchariduria (HP:0008155) | 1.80796601 |
130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80796601 |
131 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80086459 |
132 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.79593263 |
133 | Thoracic kyphosis (HP:0002942) | 1.78930455 |
134 | Epistaxis (HP:0000421) | 1.78884648 |
135 | Focal seizures (HP:0007359) | 1.77933780 |
136 | Thoracolumbar scoliosis (HP:0002944) | 1.77487147 |
137 | Keratoconjunctivitis sicca (HP:0001097) | 1.75214265 |
138 | Mitral valve prolapse (HP:0001634) | 1.74988411 |
139 | Abnormality of the lower motor neuron (HP:0002366) | 1.74736440 |
140 | Hypochromic microcytic anemia (HP:0004840) | 1.74593359 |
141 | Systemic lupus erythematosus (HP:0002725) | 1.73708856 |
142 | Abnormality of complement system (HP:0005339) | 1.73614267 |
143 | Hypolipoproteinemia (HP:0010981) | 1.72521574 |
144 | Ocular albinism (HP:0001107) | 1.72400455 |
145 | Febrile seizures (HP:0002373) | 1.72046057 |
146 | Acute hepatic failure (HP:0006554) | 1.71674715 |
147 | Pulmonary embolism (HP:0002204) | 1.71511155 |
148 | Slow saccadic eye movements (HP:0000514) | 1.71492491 |
149 | Testicular neoplasm (HP:0010788) | 1.71393488 |
150 | Encephalitis (HP:0002383) | 1.70190966 |
151 | Dysostosis multiplex (HP:0000943) | 1.69391545 |
152 | Abnormality of the axillary hair (HP:0100134) | 1.69294385 |
153 | Abnormality of secondary sexual hair (HP:0009888) | 1.69294385 |
154 | Hyperglycemia (HP:0003074) | 1.69206479 |
155 | Colitis (HP:0002583) | 1.69173302 |
156 | Prominent nose (HP:0000448) | 1.68261236 |
157 | Aortic aneurysm (HP:0004942) | 1.65767349 |
158 | Thick nail (HP:0001805) | 1.65375599 |
159 | Striae distensae (HP:0001065) | 1.65096209 |
160 | Hyporeflexia of lower limbs (HP:0002600) | 1.64309116 |
161 | Submucous cleft hard palate (HP:0000176) | 1.62099650 |
162 | Difficulty running (HP:0009046) | 1.61918914 |
163 | Action tremor (HP:0002345) | 1.61529647 |
164 | Neuronal loss in central nervous system (HP:0002529) | 1.61144468 |
165 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.61050965 |
166 | Acanthocytosis (HP:0001927) | 1.59939127 |
167 | Hypoplasia of the thymus (HP:0000778) | 1.59707482 |
168 | Obsessive-compulsive behavior (HP:0000722) | 1.59481383 |
169 | Astrocytoma (HP:0009592) | 1.57082845 |
170 | Abnormality of the astrocytes (HP:0100707) | 1.57082845 |
171 | Impaired smooth pursuit (HP:0007772) | 1.56718317 |
172 | Hypoplastic ischia (HP:0003175) | 1.56680315 |
173 | Abnormality of the periventricular white matter (HP:0002518) | 1.56118257 |
174 | Eczematoid dermatitis (HP:0000976) | 1.55645698 |
175 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.55450101 |
176 | Peripheral demyelination (HP:0011096) | 1.54559257 |
177 | Increased connective tissue (HP:0009025) | 1.54430751 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CAMK1D | 4.01050092 |
2 | CAMK1G | 3.54754032 |
3 | CDK12 | 3.02221234 |
4 | TAOK3 | 2.91710318 |
5 | BLK | 2.49674750 |
6 | RIPK1 | 2.28842279 |
7 | TTN | 2.26035253 |
8 | INSRR | 2.19895608 |
9 | TEC | 1.96989460 |
10 | AKT3 | 1.94287103 |
11 | SIK2 | 1.91085378 |
12 | PKN2 | 1.87021377 |
13 | SIK1 | 1.86107779 |
14 | NTRK3 | 1.86066095 |
15 | NLK | 1.84552661 |
16 | SGK3 | 1.80942758 |
17 | DAPK2 | 1.79744072 |
18 | PIK3CG | 1.75684842 |
19 | SGK2 | 1.68440026 |
20 | TXK | 1.65733902 |
21 | BTK | 1.65274347 |
22 | JAK1 | 1.64512392 |
23 | ACVR1B | 1.63946377 |
24 | TRIB3 | 1.62294428 |
25 | BRD4 | 1.60097665 |
26 | RIPK4 | 1.58498817 |
27 | MAP3K13 | 1.56278462 |
28 | IKBKE | 1.55767285 |
29 | SYK | 1.51983360 |
30 | BMPR2 | 1.46169499 |
31 | PTK6 | 1.38048615 |
32 | MAP3K7 | 1.35742292 |
33 | FRK | 1.26171840 |
34 | FES | 1.23377768 |
35 | TYK2 | 1.20643264 |
36 | SCYL2 | 1.20088953 |
37 | PDGFRB | 1.15809652 |
38 | PRKCH | 1.12670380 |
39 | FGFR3 | 1.11230014 |
40 | CDK6 | 1.09592433 |
41 | CAMKK1 | 1.08598374 |
42 | CAMKK2 | 1.06636403 |
43 | MTOR | 1.05054225 |
44 | JAK2 | 1.02460102 |
45 | YES1 | 1.02179395 |
46 | LATS1 | 1.00496711 |
47 | PDGFRA | 0.99780345 |
48 | STK38 | 0.99538836 |
49 | PRKAA2 | 0.96983613 |
50 | ZAP70 | 0.96495655 |
51 | PAK6 | 0.96382925 |
52 | EPHA3 | 0.96137749 |
53 | MAP3K2 | 0.95408998 |
54 | SGK1 | 0.94563349 |
55 | HCK | 0.93563190 |
56 | SGK494 | 0.91187481 |
57 | SGK223 | 0.91187481 |
58 | RET | 0.88613430 |
59 | LYN | 0.87978472 |
60 | FGFR4 | 0.87572723 |
61 | IRAK1 | 0.85961553 |
62 | MAP3K4 | 0.85518284 |
63 | FGFR2 | 0.85348846 |
64 | MAP3K14 | 0.84781314 |
65 | KIT | 0.84138885 |
66 | CAMK4 | 0.83536240 |
67 | STK24 | 0.82295244 |
68 | GRK6 | 0.81876838 |
69 | ERN1 | 0.80099397 |
70 | PRKD3 | 0.80079445 |
71 | FGR | 0.79916635 |
72 | FLT3 | 0.79737370 |
73 | CDC42BPA | 0.76943405 |
74 | PDK1 | 0.76360799 |
75 | MELK | 0.76087791 |
76 | MAP3K9 | 0.75235545 |
77 | OBSCN | 0.75124735 |
78 | PRKAA1 | 0.74897367 |
79 | NEK6 | 0.74623097 |
80 | PIK3CA | 0.74134732 |
81 | HIPK2 | 0.73301394 |
82 | PDPK1 | 0.73221582 |
83 | PTK2B | 0.71719366 |
84 | PAK3 | 0.71398129 |
85 | LMTK2 | 0.71382803 |
86 | WNK1 | 0.71324916 |
87 | PTK2 | 0.70451279 |
88 | KSR2 | 0.69265236 |
89 | IRAK4 | 0.68971468 |
90 | DMPK | 0.68107903 |
91 | MARK2 | 0.66901676 |
92 | JAK3 | 0.66656875 |
93 | MAP3K1 | 0.65469938 |
94 | MAP3K10 | 0.65251207 |
95 | CSF1R | 0.63951905 |
96 | CDK9 | 0.61640395 |
97 | MAP2K4 | 0.61479678 |
98 | TNK2 | 0.61432622 |
99 | BMX | 0.60138251 |
100 | FER | 0.60094497 |
101 | RPS6KA2 | 0.58212153 |
102 | NEK9 | 0.57304888 |
103 | PIM1 | 0.57226404 |
104 | IKBKB | 0.56848568 |
105 | TRPM7 | 0.56809291 |
106 | ICK | 0.56404296 |
107 | MAPK10 | 0.56350139 |
108 | PRPF4B | 0.56278619 |
109 | EGFR | 0.55628042 |
110 | CAMK1 | 0.54243280 |
111 | RPS6KA3 | 0.54115393 |
112 | ITK | 0.53324795 |
113 | PRKCQ | 0.53038597 |
114 | MAP2K3 | 0.52646009 |
115 | TGFBR2 | 0.51267300 |
116 | ERBB3 | 0.50176123 |
117 | RPS6KB1 | 0.49896635 |
118 | MAPK11 | 0.49624212 |
119 | STK11 | 0.48614819 |
120 | MARK3 | 0.47816362 |
121 | MAPK7 | 0.47545320 |
122 | ERBB2 | 0.46636725 |
123 | MAP4K1 | 0.45945117 |
124 | CSK | 0.45927977 |
125 | DYRK1A | 0.44996940 |
126 | MST1R | 0.43899334 |
127 | BMPR1B | 0.43836349 |
128 | EIF2AK3 | 0.43731072 |
129 | STK3 | 0.43211864 |
130 | STK38L | 0.43102743 |
131 | FYN | 0.42957003 |
132 | PRKD1 | 0.42784954 |
133 | MAP3K6 | 0.42685722 |
134 | MAPK12 | 0.41663278 |
135 | EPHA4 | 0.41657647 |
136 | CHUK | 0.40554643 |
137 | ALK | 0.40390962 |
138 | LCK | 0.39888431 |
139 | PRKDC | 0.39487181 |
140 | SRC | 0.38253618 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30190160 |
2 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.23743276 |
3 | Lysine degradation_Homo sapiens_hsa00310 | 2.22958771 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79755348 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.77539290 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68304903 |
7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64508070 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61115773 |
9 | ABC transporters_Homo sapiens_hsa02010 | 1.59688257 |
10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.58617245 |
11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56573437 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54461958 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52161725 |
14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47853736 |
15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44145812 |
16 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.43119533 |
17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42232842 |
18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.41097845 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.39372302 |
20 | Measles_Homo sapiens_hsa05162 | 1.38441467 |
21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.37929087 |
22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37870012 |
23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37728924 |
24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.36700955 |
25 | Insulin resistance_Homo sapiens_hsa04931 | 1.35046478 |
26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34988983 |
27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.27835303 |
28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27311459 |
29 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.26851964 |
30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.25835576 |
31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25732287 |
32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25176661 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.24947478 |
34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20752492 |
35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.20491716 |
36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.16477429 |
37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15843272 |
38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14508297 |
39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11800798 |
40 | Asthma_Homo sapiens_hsa05310 | 1.11630715 |
41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10572545 |
42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07672352 |
43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06784261 |
44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03864710 |
45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03698288 |
46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03326224 |
47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02797372 |
48 | Influenza A_Homo sapiens_hsa05164 | 1.01141119 |
49 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99796117 |
50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98850642 |
51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97361600 |
52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95972566 |
53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94877241 |
54 | Insulin secretion_Homo sapiens_hsa04911 | 0.94786711 |
55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93468115 |
56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93385320 |
57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92648753 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92448356 |
59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91826909 |
60 | Hepatitis B_Homo sapiens_hsa05161 | 0.91257357 |
61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88486465 |
62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88320524 |
63 | Lysosome_Homo sapiens_hsa04142 | 0.88209602 |
64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87944759 |
65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87037869 |
66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85884436 |
67 | Long-term depression_Homo sapiens_hsa04730 | 0.85808597 |
68 | Glioma_Homo sapiens_hsa05214 | 0.85568987 |
69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.84629614 |
70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84484725 |
71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83563826 |
72 | Hepatitis C_Homo sapiens_hsa05160 | 0.82920544 |
73 | Renin secretion_Homo sapiens_hsa04924 | 0.81706356 |
74 | Prostate cancer_Homo sapiens_hsa05215 | 0.81606191 |
75 | Salivary secretion_Homo sapiens_hsa04970 | 0.80268688 |
76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80247911 |
77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79304752 |
78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79260103 |
79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79052944 |
80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77449826 |
81 | Morphine addiction_Homo sapiens_hsa05032 | 0.75278134 |
82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74403275 |
83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73442693 |
84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73169422 |
85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73039620 |
86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72809202 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72118868 |
88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71498132 |
89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71335847 |
90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70931458 |
91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70724646 |
92 | Malaria_Homo sapiens_hsa05144 | 0.70671267 |
93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70214120 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70208823 |
95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69344854 |
96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69000336 |
97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67619564 |
98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67433585 |
99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66980912 |
100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66424416 |
101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65586715 |
102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65500983 |
103 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64742124 |
104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64551804 |
105 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63813457 |
106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63243862 |
107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62715730 |
108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62652895 |
109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62598819 |
110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61968147 |
111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61906298 |
112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61557651 |
113 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61072833 |
114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60351386 |
115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59696513 |
116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59660946 |
117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59464266 |
118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58687138 |
119 | Tuberculosis_Homo sapiens_hsa05152 | 0.58510468 |
120 | Platelet activation_Homo sapiens_hsa04611 | 0.58427282 |
121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58154622 |
122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56193770 |
123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55907274 |
124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55672629 |
125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55637167 |
126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54648685 |
127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52882105 |
128 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52829904 |
129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52477365 |
130 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51757564 |
131 | Amoebiasis_Homo sapiens_hsa05146 | 0.51649801 |
132 | Phagosome_Homo sapiens_hsa04145 | 0.50846961 |
133 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50749680 |
134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50396724 |
135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50391563 |
136 | Legionellosis_Homo sapiens_hsa05134 | 0.50232499 |
137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49759974 |
138 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49071490 |
139 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47887888 |
140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47688457 |
141 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47500477 |
142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47035988 |
143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46717511 |
144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46195913 |
145 | Focal adhesion_Homo sapiens_hsa04510 | 0.45287903 |
146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45015268 |
147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44852766 |
148 | Peroxisome_Homo sapiens_hsa04146 | 0.44546465 |
149 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42234392 |